Cargando…
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients
BACKGROUND: Approaches based on expression signatures of prostate cancer (PCa) have been proposed to predict patient outcomes and response to treatments. The transcription factor NF-Y participates to the progression from benign epithelium to both localized and metastatic PCa and is associated with a...
Autores principales: | Belluti, Silvia, Semeghini, Valentina, Rigillo, Giovanna, Ronzio, Mirko, Benati, Daniela, Torricelli, Federica, Reggiani Bonetti, Luca, Carnevale, Gianluca, Grisendi, Giulia, Ciarrocchi, Alessia, Dominici, Massimo, Recchia, Alessandra, Dolfini, Diletta, Imbriano, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594157/ https://www.ncbi.nlm.nih.gov/pubmed/34782004 http://dx.doi.org/10.1186/s13046-021-02166-4 |
Ejemplares similares
-
NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020) -
NF-YA Overexpression in Lung Cancer: LUSC
por: Bezzecchi, Eugenia, et al.
Publicado: (2019) -
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle
por: Rigillo, Giovanna, et al.
Publicado: (2021) -
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells
por: Belluti, Silvia, et al.
Publicado: (2018) -
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
por: Belluti, Silvia, et al.
Publicado: (2020)